10x Genomics Current Ratio 2018-2024 | TXG
10x Genomics Current Ratio Historical Data | |||
---|---|---|---|
Date | Current Assets | Current Liabilities | Current Ratio |
2024-09-30 | $0.59B | $0.12B | 4.90 |
2024-06-30 | $0.58B | $0.11B | 5.22 |
2024-03-31 | $0.57B | $0.11B | 5.22 |
2023-12-31 | $0.60B | $0.13B | 4.69 |
2023-09-30 | $0.56B | $0.11B | 5.37 |
2023-06-30 | $0.58B | $0.10B | 5.94 |
2023-03-31 | $0.60B | $0.11B | 5.37 |
2022-12-31 | $0.64B | $0.13B | 4.85 |
2022-09-30 | $0.63B | $0.13B | 4.96 |
2022-06-30 | $0.67B | $0.12B | 5.65 |
2022-03-31 | $0.70B | $0.09B | 7.38 |
2021-12-31 | $0.75B | $0.11B | 6.77 |
2021-09-30 | $0.74B | $0.10B | 7.41 |
2021-06-30 | $0.76B | $0.11B | 6.69 |
2021-03-31 | $0.75B | $0.12B | 6.19 |
2020-12-31 | $0.77B | $0.12B | 6.56 |
2020-09-30 | $0.90B | $0.15B | 6.19 |
2020-06-30 | $0.45B | $0.12B | 3.70 |
2020-03-31 | $0.43B | $0.06B | 7.28 |
2019-12-31 | $0.48B | $0.06B | 7.63 |
2019-09-30 | $0.00B | 0.00 | |
2019-06-30 | $0.00B | 0.00 | |
2019-03-31 | $0.00B | 0.00 | |
2018-12-31 | $0.11B | $0.03B | 3.28 |
2017-12-31 | $0.00B | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $1.643B | $0.619B |
10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Tempus AI (TEM) | United States | $8.497B | 0.00 |
Inspire Medical Systems (INSP) | United States | $5.276B | 164.53 |
Hims & Hers Health (HIMS) | United States | $5.141B | 130.72 |
Privia Health (PRVA) | United States | $2.533B | 211.10 |
Enovis (ENOV) | United States | $2.529B | 17.15 |
IRhythm Technologies (IRTC) | United States | $2.362B | 0.00 |
Azenta (AZTA) | United States | $2.001B | 99.78 |
Omnicell (OMCL) | United States | $1.964B | 64.26 |
Clover Health Investments (CLOV) | United States | $1.644B | 0.00 |
Schrodinger (SDGR) | United States | $1.378B | 0.00 |
Phreesia (PHR) | United States | $1.072B | 0.00 |
Butterfly Network (BFLY) | United States | $0.650B | 0.00 |
Standard BioTools (LAB) | United States | $0.562B | 0.00 |
Talkspace (TALK) | United States | $0.522B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.520B | 0.00 |
Definitive Healthcare (DH) | United States | $0.483B | 83.60 |
Health Catalyst (HCAT) | United States | $0.459B | 0.00 |
TruBridge (TBRG) | United States | $0.244B | 71.22 |
Pulmonx (LUNG) | United States | $0.237B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.214B | 0.00 |
American Well (AMWL) | United States | $0.122B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.107B | 0.00 |
P3 Health Partners (PIII) | United States | $0.075B | 0.00 |
HeartBeam (BEAT) | United States | $0.067B | 0.00 |
111 (YI) | China | $0.053B | 0.00 |
CareCloud (CCLD) | United States | $0.046B | 0.00 |
Zepp Health (ZEPP) | China | $0.040B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.040B | 0.00 |
Outset Medical (OM) | United States | $0.039B | 0.00 |
Movano (MOVE) | United States | $0.020B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.019B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.014B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.012B | 0.00 |
MSP Recovery (LIFW) | United States | $0.010B | 0.00 |
Precipio (PRPO) | United States | $0.009B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
Predictive Oncology (POAI) | United States | $0.004B | 0.00 |
Syra Health (SYRA) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.002B | 0.00 |
Zhongchao (ZCMD) | China | $0.002B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |